Overcoming Therapeutic Inertia in Type 2 Diabetes: Benefiting Patients, Clinicians, and Health Systems

Video Transcription

Video Summary

The video discusses a program on Overcoming Therapeutic Inertia in Type 2 Diabetes organized by the American Diabetes Association. The session is led by Bob Gabay, the Chief Scientific and Medical Officer, with speakers Christine Beebe, a consultant in diabetes care, and Dr. Nailin Eng, a primary care diabetologist. They emphasize the impact of therapeutic inertia on diabetes outcomes, the factors contributing to it, and strategies to address it. Key points include the progressive nature of diabetes management, the importance of clear glycemic goals and timelines, team-based approaches with diabetes education specialists, and leveraging technology for communication and monitoring. The program highlights the economic and personal burden of diabetes and stresses the importance of early intervention and optimal diabetes management. Attendees are encouraged to access resources on the ADA's website to learn more about overcoming therapeutic inertia.

Keywords

Overcoming Therapeutic Inertia

Type 2 Diabetes

American Diabetes Association

Bob Gabay

Christine Beebe

Dr. Nailin Eng

diabetes outcomes

team-based approaches

technology for communication